Synthesis and anticancer and anti-HIV testing of some pyrazino[1,2-a]benzimidazole derivatives

Eur J Med Chem. 2002 Mar;37(3):255-60. doi: 10.1016/s0223-5234(01)01313-7.

Abstract

In this study, some 1-methylene-2,3-diaryl-1,2-dihydropyrazino[1,2-a]benzimidazole and some 1-(2-arylvinyl)-3-arylpyrazino[1,2-a]benzimidazole derivatives were synthesised. The structure elucidation of the compounds was performed by IR, 1H-NMR and MASS spectroscopic data and elemental analyses results. Anticancer and anti-HIV activities of the compounds were examined, however no anti-HIV activity was seen; highly notable anticancer activity was obtained. It was also observed that the compounds were more potent against leukaemia cell lines.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / chemical synthesis*
  • Anti-HIV Agents / pharmacology*
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Benzimidazoles / chemical synthesis*
  • Benzimidazoles / pharmacology*
  • Benzimidazoles / therapeutic use
  • Cell Division / drug effects
  • Cell Line
  • Drug Evaluation, Preclinical
  • HIV / drug effects
  • Humans
  • Molecular Structure
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Substances

  • Anti-HIV Agents
  • Antineoplastic Agents
  • Benzimidazoles